REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Virsu Aptieka SIA (Latvia)

Main Activities: Pharmacies and Drug Stores
Full name: Virsu Aptieka SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Virsu Aptieka SIA is an enterprise in Latvia, with the main office in Liepaja. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on January 10, 1997. It currently has a total number of 4 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 6.87% in 2024. During that time, Virsu Aptieka SIA’s total assets grew by 8.28%. Virsu Aptieka SIA’s net profit margin increased by 1.31% in 2024.

Headquarters
Virsu iela 1A
Liepaja; Liepaja; Postal Code: 3402

Contact Details: Purchase the Virsu Aptieka SIA report to view the information.

Basic Information
Total Employees:
Purchase the Virsu Aptieka SIA report to view the information.
Registered Capital:
Purchase the Virsu Aptieka SIA report to view the information.
Financial Auditors:
Purchase the Virsu Aptieka SIA report to view the information.
Incorporation Date:
January 10, 1997
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
54%
Purchase this report to view the information.
24%
Purchase this report to view the information.
22%
Company Performance
Financial values in the chart are available after Virsu Aptieka SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
6.87%▲
Total operating revenue
6.87%▲
Operating profit (EBIT)
387.95%▲
EBITDA
387.95%▲
Net Profit (Loss) for the Period
328.55%▲
Total Assets
8.28%▲
Total Equity
86.52%▲
Operating Profit Margin (ROS)
4.55%▲
Net Profit Margin
1.31%▲
Return on Equity (ROE)
34.15%▲
Quick Ratio
0.29%▲
Cash Ratio
0.3%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo